Y-mAbs Therapeutics, Inc.

NasdaqGS:YMAB Stock Report

Mkt Cap: US$206.1m

Y-mAbs Therapeutics Company Information

Y-mAbs Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Y-mAbs Therapeutics, Inc.
  • Ticker: YMAB
  • Exchange: NasdaqGS
  • Founded: 2015
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$206.114m
  • Shares outstanding: 43.67m
  • Website: https://www.ymabs.com

Number of Employees


  • Y-mAbs Therapeutics, Inc.
  • 230 Park Avenue
  • Suite 3350
  • New York
  • New York
  • 10169
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
YMABNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDSep 2018

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/01/25 00:00
End of Day Share Price2023/01/24 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.